SELL and Alzheimer disease: Shimada et al., suggested that the elevated sL-selectin levels and abnormal L-selectin expression on some leukocyte subsets in patients with AD had correlations with AD-associated inflammation and that the serum level of sL-selectin was a serologic indicator of disease severity in AD (40).